1. Home
  2. IRON vs VTMX Comparison

IRON vs VTMX Comparison

Compare IRON & VTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$66.38

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

VTMX

Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

HOLD

Current Price

$34.86

Market Cap

2.7B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
VTMX
Founded
2017
1998
Country
United States
Mexico
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.7B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
IRON
VTMX
Price
$66.38
$34.86
Analyst Decision
Strong Buy
Hold
Analyst Count
13
3
Target Price
$99.54
$30.50
AVG Volume (30 Days)
943.0K
58.5K
Earning Date
05-29-2026
01-01-0001
Dividend Yield
N/A
1.88%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$11.54
Revenue Next Year
$215.03
$11.49
P/E Ratio
N/A
$47.91
Revenue Growth
N/A
N/A
52 Week Low
$30.82
$21.30
52 Week High
$99.50
$37.41

Technical Indicators

Market Signals
Indicator
IRON
VTMX
Relative Strength Index (RSI) 43.58 56.69
Support Level $57.45 $30.07
Resistance Level $82.70 N/A
Average True Range (ATR) 6.10 1.11
MACD 0.27 0.17
Stochastic Oscillator 73.52 46.09

Price Performance

Historical Comparison
IRON
VTMX

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

Share on Social Networks: